A sign at the New York headquarters of pharmaceutical company Pfizer Incorporated.

AstraZeneca Board Rejects New Offer From Pfizer

By
The Associated Press
WNYC News | May 19, 2014

The board of directors of British drug maker AstraZeneca says it rejects the raised $119 billion takeover offer from U.S. drugmaker Pfizer.

In a statement released Monday, AstraZeneca's board said it "reiterates its confidence in AstraZeneca's ability to deliver on its prospects as an independent, science led business."

Pfizer Inc., the world's second-biggest drugmaker by revenue, has been courting No. 8 AstraZeneca PLC since January, saying their businesses are complementary and would be stronger together. It said Sunday it was ready to raise its stock-and-cash offer by 15 percent to $118.8 billion, or 70.73 billion pounds.

AstraZeneca's board said it believes Pfizer is making "an opportunistic attempt to acquire a transformed AstraZeneca, without reflecting the value of its exciting pipeline."

Profile Image
The Associated Press

WNYC is funded by sponsors and member donations

Top Stories

Are Waymo robotaxis actually safer than NYC Uber and taxi drivers?

A new analysis concludes Waymos were involved in more serious crashes per mile than the city’s for-hire fleet.
Gothamist |

Summer Friday: Health & Ultraprocessed Food & America's History with God

For this Summer Friday, some favorite recent interviews, including our annual 'health convening' on ultraprocessed foods and Ilan Stavans on America's history with religious belief
The Brian Lehrer Show |

How Socialist Is the D.S.A.? Megan Romer Explains

Romer, a co-chair of the Democratic Socialists of America, defends some of the D.S.A.’s controversial positions: “I think people like us being rather bold. . . . People want a fighter.”
The New Yorker Radio Hour |

American History Fridays: Lady Bird Johnson

All Of It with Alison Stewart |
YOU ARE ONLINE